|
1. Byun, D.S., N. Ahmed, S. Nasser, J. Shin, S. Al-Obaidi, S. Goel, G.A. Corner, A.J. Wilson, D.J. Flanagan, D.S. Williams, L.H. Augenlicht, E. Vincan, and J.M. Mariadason, Intestinal epithelial-specific PTEN inactivation results in tumor formation. Am J Physiol Gastrointest Liver Physiol, 2011.
2. Weickhardt, A.J., N.C. Tebbutt, and J.M. Mariadason, Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway. Curr Cancer Drug Targets, 2010. 10(8): p. 824-833.
3. Wilson, A.J., A.C. Chueh, L. Togel, G.A. Corner, N. Ahmed, S. Goel, D.S. Byun, S. Nasser, M.A. Houston, M. Jhawer, H.J. Smartt, L.B. Murray, C. Nicholas, B.G. Heerdt, D. Arango, L.H. Augenlicht, and J.M. Mariadason, Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res, 2010. 70(2): p. 609-20.
4. Yuan, Z., J. Shin, A. Wilson, S. Goel, Y.H. Ling, N. Ahmed, H. Dopeso, M. Jhawer, S. Nasser, C. Montagna, K. Fordyce, L.H. Augenlicht, L.A. Aaltonen, D. Arango, T.K. Weber, and J.M. Mariadason, An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression. Cancer Res, 2009. 69(19): p. 7811-8.
5. Wilson, A.J., D.S. Byun, S. Nasser, L.B. Murray, K. Ayyanar, D. Arango, M. Figueroa, A. Melnick, G.D. Kao, L.H. Augenlicht, and J.M. Mariadason, HDAC4 promotes growth of colon cancer cells via repression of p21. Mol Biol Cell, 2008. 19(10): p. 4062-75.
6. Jhawer, M., S. Goel, A.J. Wilson, C. Montagna, Y.H. Ling, D.S. Byun, S. Nasser, D. Arango, J. Shin, L. Klampfer, L.H. Augenlicht, R. Perez-Soler, and J.M. Mariadason, PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res, 2008. 68(6): p. 1953-61.
Click Here For More
|